Evaluation of the radiation pneumonia development risk in lung cancer cases

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 17, 2014, Pages 7371-7375

  Yilmaz, Sercan ^a   Adas, Yasemin Guzle ^b   Hicsonmez, Ayse ^c   Andrieu, Meltem Nalca ^c   Akyurek, Serap ^c   Gokce, Saban Cakir ^c  

^a Diyarbakir Devlet Hastanesi   (Turkey)

^b Manisa State Hospital   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

Author keywords

Lung cancer; Prevention; Radiation pneumonitis; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVERSE EFFECTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION DOSE; RADIATION PNEUMONITIS; RADIATION RESPONSE; RETROSPECTIVE STUDY; SMALL CELL LUNG CARCINOMA;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMORADIOTHERAPY; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA;

EID: 84907271308     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.17.7371     Document Type: Article

References (18)

1. Fay M, Tan A, Fisher R, et al (2005). Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. International Journal of Radiation Oncology*Biology*Physics, 61, 1355-63.
2. Fu XL, Huang H, Bentel G, et al (2001).Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys, 50, 899-908.
3. Hernando ML, Marks LB, Bentel GC, et al (2001). Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys, 51, 650-9.
4. Kim M, Lee J, Ha B, et al (2011). Factors predicting radiation pneumonitis in locally advanced non-small cell lung cancer. Radiat Oncol J, 29, 181-90.
5. Kong FM, Hayman JA, Griffith KA, et al (2006). Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis, Int J Radiat Oncol Biol Physics, 65, 1075-86.
6. Kong FM, Hayman JA, Griffith KA, et al (2006). Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis Int J Radiat Oncol Biol Physics, 65, 1075-86.
7. Kong M,Hong SE (2014). Clinical outcome of helical tomotherapy for inoperable non-small cell lung cancer: the kyung hee university medical centre experience. Asian Pacific J Cancer Prev, 15, 1545-49.
8. Lawrence TS, Hayman J, Martel M, et al (1998). Regarding predicting radiation response. Int J Radiat Oncol Biol Phys, 41, 972-3.
9. Liu YC, Zhou SB, Gao F, et al (2013). Chemotherapy and late course three dimensional conformal radiotherapy for treatment of patients with stage III non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 2663-65.
10. Malik Ps, Malik A, Deo SV, et al (2014). Underutilization of curative treatment among patients with non small cell lung cancer :experience from a tertiary care centre in india. Asian Pac J Cancer Prev, 15, 2875-78.
11. Mehta V (2005). Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: Pulmonary function, prediction and prevention. Int J Radiation Oncology Biol Phys, 63, 5-24.
12. Ramella S, Trodella L, Mineo TC (2010). Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy. Int J Radiat Oncol Biol Phys, 76, 110-5.
13. Rancati T, Ceresolib GL, Gagliardic G (2003). Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiotherapy and Oncology, 67, 275-83.
14. Rengan R, Chetty I, Decker R, et al (2013). Lung Cancer. In:Halperin EC, Wazer DE, Perez CA et al., Editors. Perez and Brady's Principles and Practice of Radiation Oncology.6th ed.Philadelphia: Lippincott Williams and Wilkins, 938-73.
15. Schallenkamp JM, Miller RC, Brinkmann DH, et al (2007). Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys, 67, 410-6.
16. Tsujino K, Hirota S, Endo M, et al (2003). Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys, 55, 110-5.
17. Wang S, Liao Z, Wei X, et al (2006). Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys, 66, 1399-407.
18. Wang Z,Qiao YL,Tian X, et al (2012). Toll-like receptor 5 agonismprotects mice from radiation pneumonitis and pulmonary fibrosis. Asian Pac J Cancer Prev, 13, 4763-67.